Fecal transplant clinical trials for Clostridioides difficile: an interview with Sahil Khanna.

Future Microbiology
Sahil Khanna

Abstract

This interview was conducted by Atiya Henry, Commissioning Editor of Future Microbiology. Sahil Khanna is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester (MN, USA). He currently directs the Comprehensive Gastroenterology Interest group, Clostridioides difficile clinic, Fecal Microbiota Transplantation program and C. difficile related clinical trials at Mayo Clinic. He completed Medical School at the All India Institute of Medical Sciences, New Delhi; followed by Post Doctoral Research at University of California, San Diego (CA, USA); residency in Internal Medicine and Fellowship in Gastroenterology and Hepatology at Mayo Clinic, before joining the Faculty. He also completed Masters in Clinical and Translational Sciences during his fellowship. His research and clinical interests include epidemiology, outcomes and emerging therapeutics for C. difficile infection, an arena in which he has had numerous publications and presentations. He has over 100 peer-reviewed publications, serves as reviewer, is on the editorial board of several journals and has won numerous awards.

References

Nov 24, 2011·The American Journal of Gastroenterology·Sahil KhannaAlan R Zinsmeister
Feb 26, 2016·The Journal of Infectious Diseases·Sahil KhannaElizabeth L Hohmann
Feb 21, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Clifford McDonaldMark H Wilcox
Mar 15, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dale N GerdingMary Beth Dorr
Apr 5, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Erik R DubberkeDale N Gerding
Oct 31, 2019·The New England Journal of Medicine·Zachariah DeFilippElizabeth L Hohmann
Apr 6, 2020·Mayo Clinic Proceedings·Janice M ChoSahil Khanna
Apr 8, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara H McGovernMichele Trucksis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

Acta chirurgica Belgica
P VANDERHOEFT
Bulletin of the Medical Library Association
R M Hewitt
Canadian Family Physician Médecin De Famille Canadien
D Woods
Indian Journal of Plastic Surgery : Official Publication of the Association of Plastic Surgeons of India
H S Adenwalla
The Spine Journal : Official Journal of the North American Spine Society
D Fardon
© 2021 Meta ULC. All rights reserved